Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02817087 · ClinicalTrials.gov registry record · NA
Multifocal Brain Magnetic Stimulation in Chronic Ischemic Stroke
A NA study of Stroke, sponsored by David Chiu, MD.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT02817087: Completed NA study of Stroke, sponsored by David Chiu, MD.
NCT02817087 is a NA study of Stroke that has completed, run by David Chiu, MD. The registered enrollment target is 38 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02817087, a NA study of Stroke, has completed, sponsored by David Chiu, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
Transcranial magnetic stimulation for post-stroke upper-body motor deficits.
Primary Outcome
Change in number of active voxels in the cortical areas surrounding the lesion on functional MRI
Conditions Studied
Interventions
- DEVICE repetitive Transcranial Magnetic Stimulation -On
- DEVICE repetitive Transcranial Magnetic Stimulation -Off
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-05-27 |
| Est. Completion | 2019-03-13 |
| Phase | NA |
What the finished NCT02817087 record still lists
NCT02817087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which repetitive Transcranial Magnetic Stimulation -On is the first listed.
NCT02817087 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02817087 about?
NCT02817087 is a clinical study titled "Multifocal Brain Magnetic Stimulation in Chronic Ischemic Stroke". Transcranial magnetic stimulation for post-stroke upper-body motor deficits.
What is the current status of trial NCT02817087?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2016-05-27. Estimated completion is 2019-03-13.
What conditions does trial NCT02817087 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT02817087?
The interventions under investigation include: repetitive Transcranial Magnetic Stimulation -On (DEVICE), repetitive Transcranial Magnetic Stimulation -Off (DEVICE).
Who is sponsoring clinical trial NCT02817087?
This trial is sponsored by David Chiu, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02817087 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02817087's enrollment target sits among peer trials
38 275th of 454 higher than 177 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI